Next Article in Journal
Verotoxin-1 Treatment or Manipulation of its Receptor Globotriaosylceramide (Gb3) for Reversal of Multidrug Resistance to Cancer Chemotherapy
Previous Article in Journal
ADAM-15 Disintegrin-Like Domain Structure and Function
Toxins 2010, 2(10), 2428-2466; doi:10.3390/toxins2102428
Review

Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer

, , ,  and *
Received: 30 August 2010; in revised form: 23 September 2010 / Accepted: 15 October 2010 / Published: 22 October 2010
View Full-Text   |   Download PDF [1349 KB, uploaded 22 October 2010]   |   Browse Figures
Abstract: Traditional medicine and diet has served mankind through the ages for prevention and treatment of most chronic diseases. Mounting evidence suggests that chronic inflammation mediates most chronic diseases, including cancer. More than other transcription factors, nuclear factor-kappaB (NF-κB) and STAT3 have emerged as major regulators of inflammation, cellular transformation, and tumor cell survival, proliferation, invasion, angiogenesis, and metastasis. Thus, agents that can inhibit NF-κB and STAT3 activation pathways have the potential to both prevent and treat cancer. In this review, we examine the potential of one group of compounds called triterpenes, derived from traditional medicine and diet for their ability to suppress inflammatory pathways linked to tumorigenesis. These triterpenes include avicins, betulinic acid, boswellic acid, celastrol, diosgenin, madecassic acid, maslinic acid, momordin, saikosaponins, platycodon, pristimerin, ursolic acid, and withanolide. This review thus supports the famous adage of Hippocrates, “Let food be thy medicine and medicine be thy food”.
Keywords: triterpenoids; nuclear factor-κB; inflammation; tumor cell proliferation; invasion; angiogenesis; apoptosis triterpenoids; nuclear factor-κB; inflammation; tumor cell proliferation; invasion; angiogenesis; apoptosis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Yadav, V.R.; Prasad, S.; Sung, B.; Kannappan, R.; Aggarwal, B.B. Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer. Toxins 2010, 2, 2428-2466.

AMA Style

Yadav VR, Prasad S, Sung B, Kannappan R, Aggarwal BB. Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer. Toxins. 2010; 2(10):2428-2466.

Chicago/Turabian Style

Yadav, Vivek R.; Prasad, Sahdeo; Sung, Bokyung; Kannappan, Ramaswamy; Aggarwal, Bharat B. 2010. "Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer." Toxins 2, no. 10: 2428-2466.


Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert